anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

150,541-150,600 of 319,975

filter-aware
15
The slide uses a process flow diagram to illustrate the patient journey through the clinical trial.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
16
Includes detailed clinical trial data tables for a cohort of N=29 patients.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
17
Data from CARTITUDE-1 Phase 1b study presented at ASCO 2020.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
18
Swimmer plot visualization of clinical trial patient outcomes.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
19
Clinical trial summary slide for Legend Biotech.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
20
Uses a process-flow diagram to map clinical trial progression.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
21
The slide contrasts general operational status/mitigation with specific clinical trial updates (CARTITUDE/CARTIFAN).Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
22
Legend Biotech | IPO Presentation Deck | 42 slidesLegend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
23
The slide uses a structured three-part framework to explain the product's mechanism and development status.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
24
The slide uses a comparative mechanism diagram to explain the problem of CAR-T relapse and the solution provided by LB1901.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
25
The slide compares CD4+ cell percentages across different antibody treatments in CAR- and CAR+ environments.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
26
The slide shows two sets of flow cytometry plots: one set showing CAR expression levels in HH vs CAR+HH tumor cells, and another set showing the depletion of CD4+ cells by LCAR-T2C.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
27
The chart demonstrates dose-dependent tumor regression with LCAR-T2C treatment.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
28
The slide uses a structured grid to display clinical and preclinical assets.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
29
Legend Biotech | IPO Presentation Deck | 42 slidesLegend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
30
The slide uses a map to visualize the geographic distribution of manufacturing facilities and their operational status.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
31
Legend Biotech | IPO Presentation Deck | 42 slidesLegend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
32
The diagram uses a circular flow to represent a continuous process. The center features a person with the text 'Cg Courage'.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
33
The slide uses a hub-and-spoke style layout with the company logo at the center, connecting two distinct geographic commercialization strategies.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
34
Legend Biotech | IPO Presentation Deck | 42 slidesLegend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
35
The table tracks capital inflows from GenScript and JNJ, as well as a pre-IPO round.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
36
Legend Biotech | IPO Presentation Deck | 42 slidesLegend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
37
Financials are IFRS compliant and audited by E&Y.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
38
Legend Biotech | IPO Presentation Deck | 42 slidesLegend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
39
The slide uses a vertical timeline format with custom icons for each milestone.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
40
Legend Biotech | IPO Presentation Deck | 42 slidesLegend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
41
The slide uses a composite image of an Eastern-style bridge transitioning into a Western-style bridge to represent the company's unique positioning.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
42
Legend Biotech | IPO Presentation Deck | 42 slidesLegend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank 1 hit
01
Slide 1
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Attention1 hit
02
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Attention1 hit
03
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Attention1 hit
04
Strategic transformation context; includes LTM trend lines on top two charts.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
The slide uses a standard corporate reporting layout with bulleted key statements on the left and a grid of big-number metrics on the right.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
Includes a table comparing Q1 2020, Q1 2019, and FY 2019 financial metrics.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Satisfaction1 hit
08
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Satisfaction1 hit
09
Includes a broken axis on the Revenue metric to accommodate the large scale difference.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The slide uses two bar charts to compare annual historical data (2016-2019) with guidance (2020-2021) and quarterly performance (Q1 2019-Q1 2020).Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Satisfaction1 hit
11
The slide highlights the drivers of free cash flow, specifically noting the impact of lower CAPEX and working capital changes.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The chart illustrates the bridge between opening and closing net debt positions.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
13
Financial highlights slide from Maersk Q1 2020 interim report.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
14
Includes a combo chart showing EBITDA (bars) and EBITDA margin (line) over five quarters, plus a summary table comparing Q1 2020, Q1 2019, and FY 2019.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
15
The chart uses a standard waterfall bridge to explain the variance in EBITDA between two periods.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
16
Includes specific breakdown of freight rates and volumes by trade route (East-West, North-South, Intra-regional).Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
17
Part of Maersk Q1 2020 interim report.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
18
Includes a combo chart showing gross profit (bars) and margin (line) over five quarters, plus a summary table of key financial metrics.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
19
EBIT conversion ratio formula provided at the bottom.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
20
Includes a combo chart (bar/line) and a summary data table.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
21
The slide uses a structured list format to present operational and financial KPIs for the business unit.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
22
Includes a disclaimer regarding IFRS16 adjustments for 2016-2017 data.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
23
The slide highlights the impact of COVID-19 on the Qingdao factory and the performance of Maersk Supply Service.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
24
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
25
The table shows the impact of specific variables on EBITDA for the remainder of the year.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
26
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
27
Maersk | Investor Presentation Deck | 53 slidesMaersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
28
The chart displays debt maturity from 2020 to 2026+ with a breakdown of leases, bank debt, corporate bonds, and undrawn facilities.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
29
The chart includes a break in the y-axis between 10 and 40 DKK bn to accommodate the 2015 outlier.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
30
The slide uses a color-coded system (red/yellow/green) to represent growth performance relative to 2012-2018 averages.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
31
The slide highlights market share percentages and relative rankings (No. 1, No. 2, etc.) for various global trade lanes.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit
32
The slide illustrates market concentration through both individual market share and alliance groupings.Maersk | Investor Presentation Deck | 53 slides · Maersk
Conference presentation Investor relations Beat · Action1 hit